EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Decreased circulating CTRP3 levels in acute and chronic cardiovascular patients

Andreas Schmid iD, Sabine Pankuweit, Ann-Kathrin Vlacil, Sören Koch, Benedikt Berge, Praveen Gajawada, Manfred Richter, Kerstin Troidl, Bernhard Schieffer, Andreas Schäffler, Karsten Grote

Journal of Molecular Medicine · 2024

DOI: 10.1007/s00109-024-02426-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Medicine, 2024. Verfasst von Andreas Schmid und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine III, Giessen University Hospital, Giessen, Germany. andreas.schmid@innere.med.uni-giessen.de. Hauptthemen laut MEDLINE: Biomarkers. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Dr. Reinfried Pohl Foundation, Justus-Liebig-Universität Gießen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

C1q/TNF-related protein 3 (CTRP3) represents an adipokine with various metabolic and immune-regulatory functions. While circulating CTRP3 has been proposed as a potential biomarker for cardiovascular disease (CVD), current data on CTRP3 regarding coronary artery disease (CAD) remains partially contradictory. This study aimed to investigate CTRP3 levels in chronic and acute settings such as chronic coronary syndrome (CCS) and acute coronary syndrome (ACS). A total of 206 patients were classified into three groups: CCS (n = 64), ACS having a first acute event (ACS-1, n = 75), and ACS having a recurrent acute event (ACS-2, n = 67). The control group consisted of 49 healthy individuals. ELISA measurement in peripheral blood revealed decreased CTRP3 levels in all patient groups (p < 0.001) without significant differences between the groups. This effect was exclusively observed in male patients. Females generally exhibited significantly higher CTRP3 plasma levels than males. ROC curve analysis in male patients revealed a valuable predictive potency of plasma CTRP3 in order to identify CAD patients, with a proposed cut-off value of 51.25 ng/mL. The sensitivity and specificity of prediction by CTRP3 were congruent for the subgroups of CCS, ACS-1, and ACS-2 patients. Regulation of circulating CTRP3 levels in murine models of cardiovascular pathophysiology was found to be partly opposite to the clinical findings, with male mice exhibiting higher circulating CTRP3 levels than females. We conclude that circulating CTRP3 levels are decreased in both male CCS and ACS patients. Therefore, CTRP3 might be useful as a biomarker for CAD but not for distinguishing an acute from a chronic setting. Key messages CTRP3 levels were found to be decreased in both male CCS and ACS patients compared to healthy controls. Plasma CTRP3 has a valuable predictive potency in order to identify CAD patients among men and is therefore proposed as a biomarker for CAD but not for distinguishing between acute and chronic settings. Regulation of circulating CTRP3 levels in murine models of cardiovascular pathophysiology was found to be partly opposite to the clinical findings in men.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersHumansMaleFemaleMiddle AgedAgedAnimalsAcute Coronary SyndromeCardiovascular DiseasesMiceAdipokinesChronic DiseaseROC CurveTumor Necrosis FactorsCase-Control Studies

Substanzen

BiomarkersC1QTNF3 protein, humanAdipokinesTumor Necrosis Factors

Autor:innen und Institutionen

  • Department of Internal Medicine III, Giessen University Hospital, Giessen, Germany. andreas.schmid@innere.med.uni-giessen.de.
  • Cardiology and Angiology, Philipps-University Marburg, Marburg, Germany.
  • Department of Cardiac Surgery, Kerckhoff Heart Center, Bad Nauheim, Germany.
  • Department of Life Sciences and Engineering, TH Bingen, University of Applied Sciences, Bingen Am Rhein, Germany.
  • Department of Vascular and Endovascular Surgery, Cardiovascular Surgery Clinic, University Hospital Frankfurt and Wolfgang Goethe University Frankfurt, Frankfurt, Germany.
  • Department of Internal Medicine III, Giessen University Hospital, Giessen, Germany.

ORCID-Profile: Andreas Schmid

Förderung

  • Deutsche Forschungsgemeinschaft
  • Dr. Reinfried Pohl Foundation
  • Justus-Liebig-Universität Gießen

Zitieren

APA

Schmid, A., Pankuweit, S., Vlacil, A. K., Koch, S., Berge, B., Gajawada, P., Richter, M., Troidl, K., Schieffer, B., Schäffler, A., & Grote, K. (2024). Decreased circulating CTRP3 levels in acute and chronic cardiovascular patients. Journal of Molecular Medicine. https://doi.org/10.1007/s00109-024-02426-8

Vancouver

Schmid A, Pankuweit S, Vlacil AK, Koch S, Berge B, Gajawada P, et al. Decreased circulating CTRP3 levels in acute and chronic cardiovascular patients. Journal of Molecular Medicine. 2024. doi:10.1007/s00109-024-02426-8

BibTeX
@article{Schmid2024,
  author = {Schmid, Andreas and Pankuweit, Sabine and Vlacil, Ann-Kathrin and Koch, Sören and Berge, Benedikt and Gajawada, Praveen and Richter, Manfred and Troidl, Kerstin and Schieffer, Bernhard and Schäffler, Andreas and Grote, Karsten},
  title = {Decreased circulating CTRP3 levels in acute and chronic cardiovascular patients},
  journal = {Journal of Molecular Medicine},
  year = {2024},
  doi = {10.1007/s00109-024-02426-8}
}
Kostenlos starten →